Accel Research Sites named top enroller for cutting-edge Alzheimer’s disease clinical trial
In 2023, an estimated 6.7 million Americans ages 65 and older are living with Alzheimer’s disease. That number is only growing.… Read More
Category: Company News
Principal investigator discusses increase in overdoses associated with fentanyl
Lakeland recovery center seeing more patients addicted to fentanyl without knowing Recently, WFTS Tampa Bay spoke with Dr. James Anderson, principal… Read More
Tampa TV station shares stories of participants in Alzheimer’s trial
At Accel Research Sites, our participants are a huge part of why we do what we do. WFLA News Channel 8… Read More
Accel Research Sites enrolling trials for next generation of COVID vaccines
Trials for preventative vaccines available at seven sites As we enter the winter months, COVID boosters and flu shots are top-of-mind… Read More
Accel Research Sites featured in J Life Magazine
J Life Magazine, Orlando’s Jewish Lifestyle Magazine, recently published a focus story on Accel Research Sites and its President, Lora Parahovnik,… Read More
Accel Research Sites CFO David Lamadrid selected as C-Suite Award honoree by OBJ
David Lamadrid, CFO of Accel Research Sites, was chosen as one of Orlando Business Journal’s 2023 C-Suite Award honorees. Lamadrid is… Read More
Accel Research Sites Birmingham has been selected as a winner of the Birmingham Business Journal’s 2023 Alabama Inno Fire Awards. The… Read More
Accel Research Sites Network announced a new partnership with VersaTrial in April 2023, streamlining clinical operations and efficiencies within our existing… Read More
- 1
- 2
- 3
- …
- 11
- Next Page »
